Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a large prospective Uro-oncology registry.

ABSTRACT:

Objective

To evaluate the incidence and management of local and systemic complications afflicting patients with de novo metastatic prostate cancer (mPCa) in Singapore.

Design

Retrospective analysis of a large prospective Uro-oncology registry of mPCa.

Setting

This study is carried out in a tertiary hospital in Singapore.

Participants

We reviewed our institution's prospectively maintained database of 685 patients with mPCa over a 20-year period (1995-2014). Patients with non-mPCa or those progressed to metastatic disease after previous curative local treatments were excluded.

Primary and secondary outcome measures

The primary outcome was to evaluate the systemic and local morbidity rates associated with mPCa. Local complication was defined as the need for

SUBMITTER: Tan YG 

PROVIDER: S-EPMC7045104 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature